Xencor
XNCR
NZ$14.80
Share price
-2.33%
Change (1 day)
-58.43%
Change (1 year)
Categories
Xencor (XNCR) - Cash on Hand
Cash on Hand as of March 2025 : NZ$0.78 Billion
According to Xencor's latest financial reports the company has NZ$0.78 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Xencor - Cash on Hand chart (from 2012 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | NZ$0.88 B | -5.99% |
| 2023-12-31 | NZ$0.93 B | -4.33% |
| 2022-12-31 | NZ$0.98 B | 100.63% |
| 2021-12-31 | NZ$0.48 B | -41.47% |
| 2020-12-31 | NZ$0.83 B | 6.24% |
| 2019-12-31 | NZ$0.78 B | 79.25% |
| 2018-12-31 | NZ$0.43 B | 39.05% |
| 2017-12-31 | NZ$0.31 B | 67.98% |
| 2016-12-31 | NZ$0.18 B | 33.34% |
| 2015-12-31 | NZ$0.14 B | 102% |
| 2014-12-31 | NZ$69.74 M | -26.49% |
| 2013-12-31 | NZ$94.88 M | 3276.23% |
| 2012-12-31 | NZ$2.81 M | -84.91% |
| 2011-12-31 | NZ$18.62 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Seagen
SGEN | NZ$2.07 B | 163.43% | 🇺🇸 USA |
 MacroGenics MGNX | NZ$0.25 B | -67.17% | 🇺🇸 USA |
 Amgen AMGN | NZ$14.78 B | 1,776.20% | 🇺🇸 USA |
 Merck MRK | NZ$15.48 B | 1,865.22% | 🇺🇸 USA |
 Johnson & Johnson JNJ | NZ$65.07 B | 8,158.90% | 🇺🇸 USA |
 AbbVie ABBV | NZ$8.68 B | 1,002.29% | 🇺🇸 USA |